As we wait for Apple to report earnings tonight, here are some areas we’d expect Wall Street to ask about on Apple’s conference call. Apple’s conference call is winding down. Analysts have attempted ...

Each year, I take a look at the Minnesota Vikings first round picks throughout the NFL Draft process. The mock draft tracker gives us some really good data on how the industry thinks the Vikings will ...

Exclusive: President Donald Trump will interview Rick Rieder, BlackRock’s chief investment officer of global fixed income, this week to possibly be the next chairman of the Federal Reserve, ...

Privacy-focused cryptocurrencies could extend their market outperformance into 2026, according to analysts and researchers, however, the very forces driving demand ...

After military action in Venezuela, President Trump turned his attention to the rest of the hemisphere, calling an operation against Colombia “good to me” and repeating his desire for Greenland. Photo ...

In a recent interview with Schwab Network, analysts discussed the potential impact of Microsoft Corporation (NASDAQ: MSFT) Azure on Alphabet Inc.’s (NASDAQ: GOOGL) Google AI business and why they ...

It’s time to look back — and forward. By Jancee Dunn At the end of every year, I like to reflect by asking myself a question. This year, I’m mulling one recommended by Kandi Wiens, the author of ...

The unemployment rate remains low but rose to its highest level since 2021. The federal government released two major economic reports this week, easing a backlog of data pent up by the 43-day ...

If you're several chapters into a novel and forgot who a character was, Amazon is hoping its new Kindle feature will jog your memory without ever having to put the e-reader down. This feature, called ...

Advanced Micro Devices AMD shares have jumped 70.3% in the past year, outperforming the Zacks Computer and Technology sector’s 24.7% return and the Zacks Computer – Integrated Systems industry’s ...

Marvell Technology’s upbeat guidance had Wall Street cheering on Wednesday, but some analysts weren’t quite ready to pronounce a turnaround for the chip company, which has thus far been unable to ...

Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...